Journal of Interventional and General Cardiology

Cardiology Department, Alshifa Hospital, Gaza, Palestine

Publications

• Research Article   
  Colchicine for Prevention of in Stent Restenosis in Patients with Bare Metal Stents (Colisr-BMS Trial)
  Author(s): Mohammed Habib, MD, PhD*
  
  Background: In stent restenosis has been a considerable major problem with bare-metal stents (BMS). Pharmacological interventions to decrease Instent restenosis (ISR) could be of clinical relevance. Colchicine is associated with reduced inflammation and can be a reduced ISR rate when administered to patients after BMS implantation. The current study aimed to evaluate the efficacy of colchicine additional to BMS in the prevention of BMS restenosis in patients who underwent percutaneous coronary intervention (PCI). Methods: The current clinical study was conducted at Gaza city. It involved 90 patients who were scheduled for coronary angioplasty procedure. The patients were divided into three groups: The first group, underwent BMS implantation and received colchicine 0.5 mg twice daily for six months. The second group, underwent BMS implantation .. Read More»
  DOI: 10.37421/2684-4591.21.5.124

  Abstract HTML PDF